The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4'-carbamimidoylbiphenyl-4-yl)-1-methyl-1H-benzo[d]imidazole-5-carboximidamide ID: ALA4848233
PubChem CID: 164616628
Max Phase: Preclinical
Molecular Formula: C22H20N6
Molecular Weight: 368.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cn1c(-c2ccc(-c3ccc(C(=N)N)cc3)cc2)nc2cc(C(=N)N)ccc21
Standard InChI: InChI=1S/C22H20N6/c1-28-19-11-10-17(21(25)26)12-18(19)27-22(28)16-8-4-14(5-9-16)13-2-6-15(7-3-13)20(23)24/h2-12H,1H3,(H3,23,24)(H3,25,26)
Standard InChI Key: RSEIEOFGFALXDX-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
20.0053 -7.9060 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2908 -7.4935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5764 -7.9060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5764 -8.7310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8619 -9.1435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8619 -7.4935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1474 -7.9060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1474 -8.7310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3628 -8.9860 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1079 -9.7706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8779 -8.3185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0529 -8.3185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6404 -9.0330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8154 -9.0330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6404 -7.6041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8154 -7.6041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4029 -8.3185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5779 -8.3185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1654 -9.0330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3404 -9.0330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9279 -8.3185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1029 -8.3185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6904 -9.0330 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6904 -7.6041 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3404 -7.6041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1654 -7.6041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3628 -7.6511 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2908 -6.6685 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 2 0
3 6 2 0
6 7 1 0
7 8 2 0
5 8 1 0
8 9 1 0
9 10 1 0
9 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
12 15 2 0
15 16 1 0
16 17 2 0
14 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 1 0
22 24 2 0
21 25 1 0
25 26 2 0
18 26 1 0
11 27 2 0
7 27 1 0
2 28 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 368.44Molecular Weight (Monoisotopic): 368.1749AlogP: 3.48#Rotatable Bonds: 4Polar Surface Area: 117.56Molecular Species: BASEHBA: 4HBD: 4#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 6#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 11.54CX LogP: 3.00CX LogD: -1.78Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.33Np Likeness Score: -0.69
References 1. Depauw S, Lambert M, Jambon S, Paul A, Peixoto P, Nhili R, Marongiu L, Figeac M, Dassi C, Paul-Constant C, Billoré B, Kumar A, Farahat AA, Ismail MA, Mineva E, Sweat DP, Stephens CE, Boykin DW, Wilson WD, David-Cordonnier MH.. (2019) Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model., 62 (3.0): [PMID:30645099 ] [10.1021/acs.jmedchem.8b01448 ]